VYRIPHARM BIOPHARMACEUTICALS Trademark

Trademark Overview


On Friday, March 16, 2018, a trademark application was filed for VYRIPHARM BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the VYRIPHARM BIOPHARMACEUTICALS trademark a serial number of 87837447. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, September 15, 2025. This trademark is owned by Vyripharm Enterprises LLC. The VYRIPHARM BIOPHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical products development and testing of pharmaceuticals
vyripharm biopharmaceuticals

General Information


Serial Number87837447
Word MarkVYRIPHARM BIOPHARMACEUTICALS
Filing DateFriday, March 16, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, September 15, 2025
Registration Number5742875
Registration DateTuesday, May 7, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements


NOT AVAILABLE"BIOPHARMACEUTICALS"
Goods and ServicesPharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical products development and testing of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 23, 2018
Primary Code042
First Use Anywhere DateSunday, September 28, 2014
First Use In Commerce DateSunday, September 28, 2014

Trademark Owner History


Party NameVyripharm Enterprises LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77054

Party NameVyripharm Enterprises LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77021

Party NameVyripharm Enterprises LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77021

Trademark Events


Event DateEvent Description
Monday, July 2, 2018NON-FINAL ACTION WRITTEN
Monday, July 2, 2018NON-FINAL ACTION E-MAILED
Tuesday, March 20, 2018NEW APPLICATION ENTERED
Friday, March 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 27, 2018ASSIGNED TO EXAMINER
Wednesday, January 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019REGISTERED-PRINCIPAL REGISTER
Friday, September 6, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, September 6, 2019WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, October 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 5, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, February 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 7, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 15, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 15, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 15, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED